A5058405134- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiac pacing and defibrillation studies
- Coronary Interventions and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
- Takotsubo Cardiomyopathy and Associated Phenomena
- Cardiac Valve Diseases and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Syncope and Autonomic Disorders
- Infective Endocarditis Diagnosis and Management
- Heart Failure Treatment and Management
- Peripheral Artery Disease Management
- Cardiac Structural Anomalies and Repair
- Venous Thromboembolism Diagnosis and Management
- Pharmaceutical Practices and Patient Outcomes
- Medical research and treatments
- Blood Pressure and Hypertension Studies
- COVID-19 diagnosis using AI
- Infectious Aortic and Vascular Conditions
- Pharmacovigilance and Adverse Drug Reactions
- Occupational Health and Safety in Workplaces
- Ectopic Pregnancy Diagnosis and Management
- Heart Rate Variability and Autonomic Control
Hospital Universitario La Paz
2015-2024
Hospital La Paz Institute for Health Research
2024
Universidad Autónoma de Madrid
2020
Abstract Aim Cardiotoxicity (CTox) is a major side effect of cancer therapies, but uniform diagnostic criteria to guide clinical and research practices are lacking. Methods results We prospectively studied 865 patients, aged 54.7 ± 13.9; 16.3% men, scheduled for anticancer therapy related with moderate/high CTox risk. Four groups progressive myocardial damage/dysfunction were considered according current guidelines: normal, normal biomarkers (high-sensitivity troponin T N-terminal...
Baseline cardiovascular toxicity risk stratification is critical in cardio-oncology. The Heart Failure Association (HFA) and International Cardio-Oncology Society (ICOS) score aims to assess this but lacks real-life validation. This study validates the HFA-ICOS for anthracycline-induced toxicity.
Abstract Aims The actual usefulness of cardiovascular (CV) risk factor assessment in the prognostic evaluation cancer patients treated with cardiotoxic treatment remains largely unknown. Prospective multicentre study scheduled to receive anticancer therapy related moderate/high risk. Methods and results A total 1324 underwent follow-up a dedicated cardio-oncology clinic from April 2012 October 2017. Special care was given identification control CV factors. Clinical data, blood samples,...
Background: Ablation of atrial fibrillation (AF), both cryoablation ablation (CBA) and radiofrequency catheter (RFCA), have demonstrated to be safe effective. About 1 in 3 patients may face a redo due recurrence the best technique is unknown. The aim this study assess efficacy CBA as repeat procedure with prior or RFCA. Methods: A nation-wide registry (RECABA) was analyzed were compared who had previously undergone (Prior-CB) RFCA (Prior-RF). primary endpoint AF at 12 months after 3-month...
Background: Freezing rate of second-generation cryoballoon (CB) is a biophysical parameter that could assist pulmonary vein isolation. The aim this study to assess freezing (time reach –30°C ([TT-30C]) as an early predictor acute isolation using the CB. Methods: Biophysical data from CB freeze applications within multicenter, nation-wide ablation registry were gathered. Successful application (SA), was defined achieving durable intraprocedural with time in under 60 s (SA-TTI < 60) s....
Mujer de 81 años diagnosticada comunicación interventricular que debuta con inestabilidad hemodinámica tras 1 semana presentar un infarto anterior parcialmente revascularizado. Tras descartarse cirugía por muy alto riesgo quirúrgico se decide realizar abordaje cierre percutáneo del defecto. El uso la ecocardiografía resulta crucial en el diagnóstico interventricular. Las técnicas avanzadas transesofágica tridimensional permiten una adecuada evaluación las dimensiones interventricular, así...